We are live on ! Find out more
Jane Street

Jane Street Portfolio holdings

AUM $777B
1-Year Est. Return 61.18%
 

Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.

This Fund
S&P 500
This Quarter Est. Return
-1.27%
1 Year Est. Return
+61.18%
3 Year Est. Return
+147.64%
5 Year Est. Return
+157.48%
10 Year Est. Return
+673.77%
AUM
$283B
AUM Growth
+$27.4B
Cap. Flow
+$30.5B
Cap. Flow %
10.78%
Top 10 Hldgs %
36.77%
Holding
11,338
New
1,654
Increased
4,102
Reduced
3,903
Closed
1,507

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 2.35%
2 Technology 1.76%
3 Financials 1%
4 Communication Services 0.83%
5 Healthcare 0.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPAY icon
6901
PUT
Corpay
CPAY
$27.9B
$601K ﹤0.01%
2,300
BKD icon
6902
CALL
Brookdale Senior Living
BKD
$3B
$600K ﹤0.01%
95,300
-2,500
-3% -$17.8K
BRO icon
6903
Brown & Brown
BRO
$24B
$600K ﹤0.01%
10,815
-15,428
-59% -$860K
CNNE icon
6904
Cannae Holdings
CNNE
$675M
$600K ﹤0.01%
19,293
+8,805
+84% +$283K
HRTX icon
6905
Heron Therapeutics
HRTX
$63.5M
$600K ﹤0.01%
56,147
+46,085
+458% +$561K
MKC icon
6906
PUT
McCormick & Company Non-Voting
MKC
$14.6B
$600K ﹤0.01%
7,400
+500
+7% +$42.9K
XSLV icon
6907
Invesco S&P SmallCap Low Volatility ETF
XSLV
$250M
$600K ﹤0.01%
12,736
-12,759
-50% -$605K
KOPN icon
6908
PUT
Kopin
KOPN
$898M
$599K ﹤0.01%
116,800
+36,000
+45% +$219K
RVTY icon
6909
Revvity
RVTY
$13.1B
$599K ﹤0.01%
3,453
-22,692
-87% -$4M
XRLV
6910
DELISTED
Invesco S&P 500 ex-Rate Sensitive Low Volatility ETF
XRLV
$599K ﹤0.01%
12,821
-1,065
-8% -$51.4K
DJCB
6911
DELISTED
ETRACS Bloomberg Commodity Index Total Return ETN Series B due October 31, 2039
DJCB
$599K ﹤0.01%
31,303
+13,941
+80% +$252K
EDOG icon
6912
ALPS Emerging Sector Dividend Dogs ETF
EDOG
$29.5M
$598K ﹤0.01%
+24,434
New +$597K
EFZ icon
6913
ProShares Trust Short MSCI EAFE
EFZ
$9.96M
$598K ﹤0.01%
16,219
-32,771
-67% -$1.18M
MLKN icon
6914
MillerKnoll
MLKN
$1.62B
$598K ﹤0.01%
15,880
-8,278
-34% -$355K
PLL
6915
DELISTED
Piedmont Lithium
PLL
$598K ﹤0.01%
+10,979
New +$638K
PRPC.U
6916
DELISTED
CC Neuberger Principal Holdings III Units, each consisting of one Class A ordinary share, and one-fifth of one redeemable warrant
PRPC.U
$598K ﹤0.01%
60,091
+579
+1% +$5.78K
IBDU icon
6917
iShares iBonds Dec 2029 Term Corporate ETF
IBDU
$4.07B
$597K ﹤0.01%
22,435
-73,127
-77% -$1.97M
MTSI icon
6918
CALL
MACOM Technology Solutions
MTSI
$23.5B
$597K ﹤0.01%
9,200
-11,600
-56% -$713K
GTHX
6919
CALL
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$597K ﹤0.01%
44,500
-8,700
-16% -$142K
VBIV
6920
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$597K ﹤0.01%
6,393
-309
-5% -$29.4K
AUD
6921
DELISTED
Audacy, Inc.
AUD
$597K ﹤0.01%
162,012
+98,613
+156% +$345K
BHVN
6922
PUT
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$597K ﹤0.01%
+4,300
New +$537K
ZWRK
6923
DELISTED
Z-Work Acquisition Corp. Class A Common Stock
ZWRK
$596K ﹤0.01%
61,221
+2,219
+4% +$21.5K
Y
6924
DELISTED
Alleghany Corp
Y
$596K ﹤0.01%
955
-7,635
-89% -$5.04M
KTB icon
6925
Kontoor Brands
KTB
$4.65B
$595K ﹤0.01%
11,909
-34,554
-74% -$1.92M

Similar funds

Jane Street's Q3 2021 Portfolio in Review

As of Q3 2021, Jane Street held 11,338 positions worth $283B, up 11% from $256B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Jane Street deployed $30.5B of net new capital in Q3 2021, opening 1,654 new positions and adding to 4,102 existing holdings. Its largest new stake was Vanguard FTSE Europe ETF: 5,046,582 shares worth $331M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 2.3% of assets, down from 2.5% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was iShares MBS ETF, an estimated $1.01B trimmed.

  • Jane Street's largest Q3 2021 buy was Vanguard FTSE Europe ETF: 5,046,582 shares worth $331M.
  • Jane Street added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $1.64B increase.
  • Jane Street's biggest Q3 2021 reduction was iShares MBS ETF, cutting an estimated $1.01B.
  • Jane Street fully exited Vanguard Tax-Exempt Bond Index Fund in Q3 2021, selling an estimated $338M.
  • Jane Street's ten largest holdings make up 37% of its $283B portfolio in Q3 2021.
  • Jane Street opened 1,654 new positions and closed 1,507 in Q3 2021.
  • Jane Street's portfolio value rose 11% quarter-over-quarter to $283B.

Based on Jane Street's 13F filing for Q3 2021, filed 16 Nov 2021.